• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道细菌在匹可硫酸钠转化中的作用。

The role of intestinal bacteria in the transformation of sodium picosulfate.

作者信息

Kim D H, Hyun S H, Shim S B, Kobashi K

机构信息

Department of Microbiology, College of Pharmacy, Kyung-Hee University, Seoul, Korea.

出版信息

Jpn J Pharmacol. 1992 May;59(1):1-5. doi: 10.1254/jjp.59.1.

DOI:10.1254/jjp.59.1
PMID:1507649
Abstract

Sodium picosulfate, a laxative, was biotransformed to 4,4'-dihydroxydiphenyl-(2 pyridyl)-methane by intestinal flora that produced a novel sulfotransferase (not sulfatase). The biotransformation was activated by adding phenolic compounds such as phenol, acetaminophen and flavonoids. The enzyme activity related to this biotransformation was the highest in the contents of the caecum region of the intestine. The enzyme activity was 3.0 mumole/hr/g wet feces in humans and 0.75 in rats (pH 8.0). The optimal pH was 9.0.

摘要

比沙可啶是一种泻药,经肠道菌群生物转化为4,4'-二羟基二苯基-(2-吡啶基)-甲烷,该肠道菌群产生了一种新型磺基转移酶(而非硫酸酯酶)。添加酚类化合物如苯酚、对乙酰氨基酚和类黄酮可激活这种生物转化。与这种生物转化相关的酶活性在肠道盲肠区域内容物中最高。该酶活性在人类粪便湿重中为3.0微摩尔/小时/克,在大鼠中为0.75微摩尔/小时/克(pH 8.0)。最适pH为9.0。

相似文献

1
The role of intestinal bacteria in the transformation of sodium picosulfate.肠道细菌在匹可硫酸钠转化中的作用。
Jpn J Pharmacol. 1992 May;59(1):1-5. doi: 10.1254/jjp.59.1.
2
Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.双(对羟基苯基)-吡啶-2-甲烷:比沙可啶和匹可硫酸钠的常见致泻成分。
Arzneimittelforschung. 1975 Nov;25(11):1796-1800.
3
Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women.双羟苯丁哌啶和聚乙二醇 4000 钠在人乳中无分泌:健康哺乳期妇女的开放性、平行组、多剂量研究。
Drug Metab Pharmacokinet. 2011;26(5):458-64. doi: 10.2133/dmpk.dmpk-11-rg-007. Epub 2011 Jun 21.
4
Interaction between Shaoyao-Gancao-Tang and a laxative with respect to alteration of paeoniflorin metabolism by intestinal bacteria in rats.芍药甘草汤与一种泻药对大鼠肠道细菌改变芍药苷代谢的相互作用。
Phytomedicine. 2007 Aug;14(7-8):452-9. doi: 10.1016/j.phymed.2006.09.014. Epub 2006 Nov 9.
5
Sulfation of phenolic antibiotics by sulfotransferase obtained from a human intestinal bacterium.人肠道细菌来源的硫酸转移酶对酚类抗生素的硫酸化作用
Chem Pharm Bull (Tokyo). 1992 Apr;40(4):1056-7. doi: 10.1248/cpb.40.1056.
6
bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM)-the active metabolite of the laxatives bisacodyl and sodium picosulfate-enhances contractility and secretion in human intestine in vitro.双-(对羟苯基)-吡啶-2-甲烷(BHPM)是缓泻剂比沙可啶和聚卡波非钙的活性代谢物,可增强人肠体外的收缩和分泌功能。
Neurogastroenterol Motil. 2018 Jul;30(7):e13311. doi: 10.1111/nmo.13311. Epub 2018 Feb 14.
7
A novel type of aryl sulfotransferase obtained from an anaerobic bacterium of human intestine.一种从人类肠道厌氧菌中获得的新型芳基磺基转移酶。
Arch Biochem Biophys. 1986 Mar;245(2):537-9. doi: 10.1016/0003-9861(86)90247-x.
8
Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study).在身体残疾的门诊人群中,以聚乙二醇电解质溶液联合比沙可啶作为对照,评价匹可硫酸钠/柠檬酸镁进行肠道准备的疗效和安全性:一项随机、内镜医师设盲比较的研究(PICO-MOVI 研究)。
Dis Colon Rectum. 2018 Feb;61(2):239-249. doi: 10.1097/DCR.0000000000000956.
9
Effects of sodium picosulfate, bisacodyl and sennoside in cultured human, rat and rabbit liver cells.比沙可啶、番泻苷和匹可硫酸钠对人、大鼠及兔培养肝细胞的作用。
Arzneimittelforschung. 1981;31(6):1010-3.
10
Sulfation of parabens and tyrosylpeptides by bacterial arylsulfate sulfotransferases.细菌芳基硫酸酯磺基转移酶对对羟基苯甲酸酯和酪氨酰肽的硫酸化作用。
Biol Pharm Bull. 1994 Oct;17(10):1326-8. doi: 10.1248/bpb.17.1326.

引用本文的文献

1
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.微生物代谢的奇迹:微生物药物转化能力的综合评述。
Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16.
2
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era.精准医学时代人类肠道微生物群与药物相互作用的机制及临床意义
Biomedicines. 2024 Jan 16;12(1):194. doi: 10.3390/biomedicines12010194.
3
Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage.
剖析人类肠道微生物群以更好地解读药物安全性:一个曾被遗忘的器官成为焦点。
J Adv Res. 2023 Oct;52:171-201. doi: 10.1016/j.jare.2023.07.002. Epub 2023 Jul 5.
4
The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine.肠道微生物群与口服药物之间的相互作用及其对推进精准医学的影响。
Metabolites. 2023 May 21;13(5):674. doi: 10.3390/metabo13050674.
5
Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice.临床实践中胃肠道微生物群对药物代谢的机制。
Saudi Pharm J. 2019 Dec;27(8):1146-1156. doi: 10.1016/j.jsps.2019.09.011. Epub 2019 Oct 24.
6
How to Determine the Role of the Microbiome in Drug Disposition.如何确定微生物组在药物处置中的作用。
Drug Metab Dispos. 2018 Nov;46(11):1588-1595. doi: 10.1124/dmd.118.083402. Epub 2018 Aug 15.
7
Upper airway obstruction resulting from acute mucosal injury induced by direct ingestion of sodium picosulfate/magnesium citrate powder.直接摄入比沙可啶/枸橼酸镁粉引起急性黏膜损伤导致上呼吸道梗阻。
Clin Exp Emerg Med. 2016 Jun 30;3(2):109-111. doi: 10.15441/ceem.15.023. eCollection 2016 Jun.
8
Gut microbiome interactions with drug metabolism, efficacy, and toxicity.肠道微生物群与药物代谢、疗效及毒性的相互作用。
Transl Res. 2017 Jan;179:204-222. doi: 10.1016/j.trsl.2016.08.002. Epub 2016 Aug 13.
9
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment).共识声明:AIGO/SICCR 慢性便秘和排便障碍的诊断和治疗(第二部分:治疗)。
World J Gastroenterol. 2012 Sep 28;18(36):4994-5013. doi: 10.3748/wjg.v18.i36.4994.
10
Mechanism of action and toxicities of purgatives used for colonoscopy preparation.泻药用于结肠镜检查准备的作用机制和毒性。
Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):89-101. doi: 10.1517/17425255.2011.542411.